Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000793974 | SCV000933356 | uncertain significance | MHC class I deficiency | 2022-11-03 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 552 of the TAP2 protein (p.Glu552Gly). This variant is present in population databases (rs151064661, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TAP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 640861). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV000793974 | SCV002099052 | uncertain significance | MHC class I deficiency | 2021-03-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692254 | SCV005188889 | uncertain significance | not provided | criteria provided, single submitter | not provided |